| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K04800985 | CTRPv2 | pan-cancer | AAC | -0.15 | 9e-05 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0002 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | 0.17 | 0.0003 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | 0.16 | 0.0003 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0004 |
| mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0004 |
| mRNA | Genentech Cpd 10 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0005 |
| mRNA | isonicotinohydroxamic acid | CTRPv2 | pan-cancer | AAC | -0.16 | 0.0007 |
| mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.001 |
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.001 |